Coherent Market Insights published a business research report on Visceral Pain Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2022–2028. Visceral Pain Treatment Market with 150+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. The information is gathered based on modern floats and requests identified with the administrations and items.
Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/4095
Visceral pain is an internal pain which occur due to inflammation of internal organs. This inflammation happens due to various factors such as infection, trauma, or any injury outside or inside of the internal organs.
Investment by the governments of various countries and pharmaceutical companies in research & development to develop novel drugs, is expected to propel the global visceral pain treatment market growth. Moreover, the growing prevalence of irritable bowel syndrome is again projected to boost the market growth. For instance, according to the International Foundation for Gastrointestinal Disorders (IFFGD) in 2016, up to 10% to 15% of adults all over the world are affected by irritable bowel syndrome (IBS) every year.
Visceral Pain Treatment Market – Impact of Coronavirus (Covid-19) Pandemic
Visceral pain treatment market size is hugely affected due to the outbreak of COVID-19 across the globe. In clinical trials, the possibility of visceral abdominal pain has major implications during the COVID-19 pandemic. When COVID-19 patients report severe abdominal pain, the visceral infarction should be considered in disparity diagnosis and should be taken into account in imaging diagnostics and laboratory workups. It is challenging for key players and researchers to perform clinical trials during the pandemic. On the contrary, several market players and governments are investing in R&D activities for the development of novel drugs for visceral pain.
The all-inclusive version of the report will include the impact of COVID-19 and the probable changes in the future outlook of the industry, by taking into account the technological, social, political, and economical parameters.
The global visceral pain treatment market is estimated to be valued at US$ 11,673.8 million in 2020 and is expected to rise at a CAGR of 5.2% during the forecast period (2020-2027).
Rise in the number of clinical trials, research & development activities, and drug approvals is supporting visceral pain treatment market growth
Key players in the market are heavily investing in research & development and performing clinical trials to develop novel drugs in the visceral pain treatment market. The drug approvals in the market are expected to significantly fuel the market growth and create lucrative growth opportunities in the visceral pain treatment market during the forecast period.
For instance, in January 2019, Ironwood Pharmaceuticals Inc. announced the approval of ‘LINZESS’ of strength 72 mcg, 145 mcg, and 290 mcg in China for the treatment of irritable bowel syndrome (IBS) with constipation in adults. Ironwood and AstraZeneca jointly developed and commercialized linaclotide (LINZESS) in China. Ironwood estimated that it will launch the drug by 2020. Such approvals are likely to enhance the availability of drugs in potential markets, which is benefiting growth of the global visceral pain treatment market.
Furthermore, key players in the industry are adopting growth strategies such as collaborations and joint agreements to strengthen their market position. For instance, in February 2020, the Drugs for Neglected Diseases initiative (DNDi) and Novartis entered into a collaborative license agreement to co-develop ‘LXE408’ as a potential novel treatment for visceral leishmaniasis, which is one of the leading parasitic killers of the world. LXE408 which is a first-in-class compound, was discovered with financial support from Welcome Trust at Novartis.
Global Visceral Pain Treatment Market – Restraints
On the other hand, lack of specific treatment for visceral pain such as irritable bowel and Crohn’s disease is a major factor, is expected to restrict growth of the visceral pain treatment market. Moreover, competition amongst the key industry players regarding the development of novel drugs for visceral pain is projected to be a key reason that is projected to restrict the market growth.
Additionally, the high cost of drugs is again expected to be a major challenges to growth of the visceral pain treatment market.
Global Visceral Pain Treatment Market – Regional Analysis
North America accounted for majority of share in the visceral pain treatment market in 2019 and is expected to gain fastest growth in the industry during the forecast period. This dominance is majorly due to growing focus of pharmaceutical companies on R&D and joint ventures to develop novel drugs for visceral pain. For instance, in March 2018, Arena Pharmaceuticals presented preclinical data and phase 1 data on APD371 for development of pain treatment related to Crohn’s disease at the APS (American Pain Society) Annual Scientific Summit at San Diego. APD371 or Olorinab is an oral, highly-selective, peripherally acting discovered investigational drug for the visceral pain treatment associated with gastrointestinal disorders.
Moreover, the growing prevalence of irritable bowel syndrome and Crohn’s disease is projected to augmenr growth of the regional market. For instance, according to the estimations published in the Gastroenterology & Hepatology Journal (G&H) in 2016, Crohn’s disease is one of the most common indications of visceral pain and its prevalence in the North America region is between 400 and 600 cases per 100,000 people. According to the Centers for Disease Control and Prevention (CDC), around 3 million people were diagnosed with irritable bowel disease (IBD) such as ulcerative colitis or Crohn’s disease in 2015.
Furthermore, Asia Pacific region is expected to grow at the fastest pace over the forecast period, due to growing investments by pharma companies and governments initiatives visceral pain treatment. For instance, companies such as Glenmark Pharmaceuticals, Takeda Pharmaceutical Company, and others offer visceral pain products and treatment in the Asia Pacific region. Moreover, government authorities such as the government of Australia are focused on growing awareness regarding visceral pain and its treatment.
Global Visceral Pain Treatment Market – Competitive Landscape
Addex Therapeutics Ltd., AstraZeneca, Astellas Pharma Inc., Allergan, Chromocell Corporation, Takeda, GIcare Pharma Inc., Abbvie, Grunenthal GmbH, Johnson & Johnson, Neurim Pharmaceuticals Ltd, and Medestea Research & Production S.p.A.
Buy This Report With USD 2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/4095
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Visceral Pain Treatment Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Visceral Pain Treatment Industry Impact
Chapter 2 Global Visceral Pain Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Visceral Pain Treatment (Volume and Value) by Type
2.3 Global Visceral Pain Treatment (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Visceral Pain Treatment Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Visceral Pain Treatment Market Analysis
Chapter 6 East Asia Visceral Pain Treatment Market Analysis
Chapter 7 Europe Visceral Pain Treatment Market Analysis
Chapter 8 South Asia Visceral Pain Treatment Market Analysis
Chapter 9 Southeast Asia Visceral Pain Treatment Market Analysis
Chapter 10 Middle East Visceral Pain Treatment Market Analysis
Chapter 11 Africa Visceral Pain Treatment Market Analysis
Chapter 12 Oceania Visceral Pain Treatment Market Analysis
Chapter 13 South America Visceral Pain Treatment Market Analysis
Chapter 14 Company Profiles and Key Figures in Visceral Pain Treatment Business
Chapter 15 Global Visceral Pain Treatment Market Forecast (2021-2027)
Chapter 16 Conclusions
Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/4095
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027